Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians

HIV Medicine

Volumn 13, Issue 7, 2012, Pages 387-397

  Huber, M ^a   Ledergerber, B ^a   Sauter, R ^b   Young, J ^c   Fehr, J ^a   Cusini, A ^d   Battegay, M ^e   Calmy, A ^f   Orasch, C ^g   Nicca, D ^h   Bernasconi, E ⁱ   Jaccard, R ^j   Held, L ^b   Weber, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^h CANTONAL HOSPITAL ST GALLEN   (Switzerland)

ⁱ REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^j 'HIV Pract' (Private Practices)   (Switzerland)

more..

Author keywords

Cardiovascular risk factors; HIV infection; Prochaska Di Clemente model on behaviour change; Smoking; Smoking cessation counselling

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; DRUG USE; EDUCATION PROGRAM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL SPECIALIST; MENTAL DISEASE; MOTIVATION; OUTCOME ASSESSMENT; PATIENT COUNSELING; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; SMOKING CESSATION; SWITZERLAND;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; DIRECTIVE COUNSELING; FEMALE; HIV SEROPOSITIVITY; HUMANS; INSERVICE TRAINING; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; MOTIVATION; ODDS RATIO; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SMOKING CESSATION; SUBSTANCE-RELATED DISORDERS; SWITZERLAND;

EID: 84859416050     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2011.00984.x     Document Type: Article

References (36)

1. Friis-Moller N, Weber R, Reiss P etal. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS 2003; 17: 1179-1193.
2. Monforte A, Abrams D, Pradier C etal. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS 2008; 22: 2143-2153.
3. Petoumenos K, Worm S, Reiss P etal. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study. HIV Med 2011; 12: 412-421.
4. Weber R, Sabin CA, Friis-Moller N etal. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006; 166: 1632-1641.
5. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006; 145: 397-406.
6. Hasse B, Ledergerber B, Furrer H etal. Morbidity and aging in HIV-infected persons: the Swiss HIV Cohort Study. Clin Infect Dis 2011; 53: 1130-1139.
7. Rigotti NA. Treatment of tobacco use and dependence. N Engl J Med 2002; 346: 506-512.
8. Srivastava P, Currie GP, Britton J. Smoking cessation. BMJ 2006; 332: 1324-1326.
9. Raw M, Regan S, Rigotti NA, McNeill A. A survey of tobacco dependence treatment guidelines in 31 countries. Addiction 2009; 104: 1243-1250.
10. Fiore MCA. Treating tobacco use and dependence. 2008 Update. Available at (accessed 21 October 2011).
11. Anderson JE, Jorenby DE, Scott WJ, Fiore MC. Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. Chest 2002; 121: 932-941.
12. Cupertino AP, Wick JA, Richter KP, Mussulman L, Nazir N, Ellerbeck EF. The impact of repeated cycles of pharmacotherapy on smoking cessation: a longitudinal cohort study. Arch Intern Med 2009; 169: 1928-1930.
13. Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav 2009; 13: 545-554.
14. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2008; (2) CD000165.
15. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav 2010; 14: 824-835.
16. Bao Y, Duan N, Fox SA. Is some provider advice on smoking cessation better than no advice? An instrumental variable analysis of the 2001 National Health Interview Survey. Health Serv Res 2006; 41: 2114-2135.
17. Crothers K, Goulet JL, Rodriguez-Barradas MC etal. Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med 2007; 22: 749-754.
18. Humair JP, Cornuz J. A new curriculum using active learning methods and standardized patients to train residents in smoking cessation. J Gen Intern Med 2003; 18: 1023-1027.
19. Cornuz J, Humair JP, Seematter L etal. Efficacy of resident training in smoking cessation: a randomized, controlled trial of a program based on application of behavioral theory and practice with standardized patients. Ann Intern Med 2002; 136: 429-437.
20. Elzi L, Spoerl D, Voggensperger J etal. A smoking cessation programme in HIV-infected individuals: a pilot study. Antivir Ther 2006; 11: 787-795.
21. Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis 2000; 31: 808-812.
22. Vidrine DJ. Cigarette smoking and HIV/AIDS: health implications, smoker characteristics and cessation strategies. AIDS Educ Prev 2009; 21: 3-13.
23. Fuster M, Estrada V, Fernandez-Pinilla MC etal. Smoking cessation in HIV patients: rate of success and associated factors. HIV Med 2009; 10: 614-619.
24. Schoeni-Affolter F, Ledergerber B, Rickenbach M etal. Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol 2010; 39: 1179-1189.
25. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol 1992; 47: 1102-1114.
26. Agboola S, McNeill A, Coleman T, Leonardi Bee J. A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers. Addiction 2010; 105: 1362-1380.
27. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293-298.
28. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing Vienna, Austria. Available at (accessed 28 September 2011).
29. Marques-Vidal P, Cerveira J, Paccaud F, Cornuz J. Smoking trends in Switzerland, 1992-2007: a time for optimism? J Epidemiol Community Health 2011; 65: 281-286.
30. Keller R, Radtke T, Krebs H, Hornung R. Der Tabakkonsum der Schweizer Wohnbevölkerung in den Jahren. 2001 bis 2010. Available at (accessed 21 June 2011).
31. Bundesamt für Statistik. Statistisches Lexikon der Schweiz. Available at (accessed 21 October 2011).
32. Aronson JK. Biomarkers and surrogate endpoints. Br J Clin Pharmacol 2005; 59: 491-494.
33. Hughes JR. How confident should we be that smoking cessation treatments work? Addiction 2009; 104: 1637-1640.
34. Jepson RG, Harris FM, Platt S, Tannahill C. The effectiveness of interventions to change six health behaviours: a review of reviews. BMC Public Health 2010; 10: 538-554.
35. Silagy CA, Stead LF, Lancaster T. Use of systematic reviews in clinical practice guidelines: case study of smoking cessation. BMJ 2001; 323: 833-836.
36. Aveyard P, Brown K, Saunders C etal. Weekly versus basic smoking cessation support in primary care: a randomised controlled trial. Thorax 2007; 62: 898-903.